Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug-drug interaction potentials of tucatinib inhibition of human UDP-glucuronosyltransferases. | Chem Biol Interact | 2023 | 37263554 | PubTator, text mining | PubMed |
| Personalized Dual Antiplatelet Therapy in Acute Coronary Syndromes: Striking a Balance Between Bleeding and Thrombosis. | Curr Cardiol Rep | 2023 | 37261665 | PubTator, text mining | PubMed |
| Pharmacogenetics of pain management in Zimbabwean patients with sickle cell disease. | Pharmacogenomics | 2023 | 37248824 | PubTator, text mining | PubMed |
| Chemical Constitution, Pharmacological Effects and the Underlying Mechanism of Atractylenolides: A Review. | Molecules | 2023 | 37241729 | PubTator, text mining | PubMed |
| Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy. | J Pers Med | 2023 | 37240999 | PubTator, text mining | PubMed |
| Association between Food/UGT2B7 Polymorphisms and Pharmacokinetics/Pharmacodynamics Properties of Indapamide in Healthy Humans. | Biomedicines | 2023 | 37239171 | PubTator, text mining | PubMed |
| The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review. | Pharmgenomics Pers Med | 2023 | 37223718 | PubTator, text mining | PubMed |
Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial. | Clin Cardiol | 2023 | 37191146 | PubTator, text mining | PubMed |
| Cannabis Pharmacogenomics: A Path to Personalized Medicine. | Curr Issues Mol Biol | 2023 | 37185752 | PubTator, text mining | PubMed |
| A genomic enhancer signature associates with hepatocellular carcinoma prognosis. | JHEP Rep | 2023 | 37168287 | PubTator, text mining | PubMed |
| Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity. | Front Genet | 2023 | 37152993 | PubTator, text mining | PubMed |
| Clinical outcomes of chemotherapy in cancer patients with different ethnicities. | Cancer Rep (Hoboken) | 2023 | 37150853 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic Modeling for Multiple Oral Administration Labetalol in Pregnant Women. | Pharm Res | 2023 | 37142805 | PubTator, text mining | PubMed |
| A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution. | Pharmaceutics | 2023 | 37111707 | PubTator, text mining | PubMed |
| In Silico Analyses of a Promising Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis Targeting Superoxide Dismutase I Protein. | Pharmaceutics | 2023 | 37111580 | PubTator, text mining | PubMed |
| Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl-tRNA synthetase inhibitor, in healthy subjects. | Clin Transl Sci | 2023 | 37095713 | PubTator, text mining | PubMed |
| Identification of Hub Genes and Immune Infiltration in Non-alcoholic Fatty Liver Disease -Related Hepatocellular Carcinoma by Bioinformatics Analysis. | Turk J Gastroenterol | 2023 | 37089050 | PubTator, text mining | PubMed |
| The utility of 3D models to study cholesterol in cancer: Insights and future perspectives. | Front Oncol | 2023 | 37077827 | PubTator, text mining | PubMed |
| The Polypharmacological Effects of Cannabidiol. | Molecules | 2023 | 37050032 | PubTator, text mining | PubMed |
| Intestinal Metabolism of Diclofenac by Polymorphic UGT2B17 Correlates with its Highly Variable Pharmacokinetics and Safety across Populations. | Clin Pharmacol Ther | 2023 | 37042794 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=12